TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521).

Yanik, Gregory A

TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521). [electronic resource] - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Jan 2015 - 67-73 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1523-6536

10.1016/j.bbmt.2014.09.019 doi


Adolescent
Adrenal Cortex Hormones--therapeutic use
Bronchoalveolar Lavage Fluid--chemistry
Child
Child, Preschool
Cytokines--biosynthesis
Drug Therapy, Combination
Etanercept
Female
Hematologic Neoplasms--immunology
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Idiopathic Interstitial Pneumonias--etiology
Immunoglobulin G--therapeutic use
Immunosuppressive Agents--therapeutic use
Infant
Male
Receptors, Tumor Necrosis Factor--antagonists & inhibitors
Respiration, Artificial
Siblings
Survival Analysis
Transplantation, Homologous
Treatment Outcome
Unrelated Donors